| 000 | 012270000a22003490004500 | ||
|---|---|---|---|
| 003 | PH-MaWHO | ||
| 005 | 20241108112606.0 | ||
| 020 | _a3456820275 | ||
| 090 | _aUJ.RB 1993 | ||
| 100 |
_aGrof, Paul... [ et al.]. _9668531 |
||
| 264 |
_aBern : _bHogrefe and Huber Publishers on behalf of the WHO, _c1993. |
||
| 490 | _aWHO expert series on biological psychiatry ; vol. 2. | ||
| 700 |
_aAkhter, M. Iftikhar _9668532 |
||
| 700 |
_aCampbell, Magda _9668533 |
||
| 700 |
_aGottfries, Carl G. _9668534 |
||
| 700 |
_aKhan, Inayat _9652885 |
||
| 700 |
_aLapierre, Yvon D. _9668535 |
||
| 700 |
_aLemberger, Louis _9668536 |
||
| 700 |
_aMnller-Oerlinghausen, Bruno _9668537 |
||
| 700 |
_aWoggon, Brigitte _9668538 |
||
| 710 |
_aWorld Health Organization. _9641634 |
||
| 245 | _aClinical evaluation of psychotropic drugs for psychiatric disorders : principles and proposed guidelines. | ||
| 300 | _a202p. | ||
| 041 | _aeng | ||
| 650 |
_aDrug Evaluation _xStandards _9139406 |
||
| 650 |
_aDrug utilization _9139634 |
||
| 650 |
_aMental disorders _xDrug therapy _981341 |
||
| 650 |
_aPsychotropic drugs _9292119 |
||
| 650 |
_aSubstance-related disorders _9448064 |
||
| 040 | _aWHOLIS | ||
| 942 |
_cMONO _gMark 13-10-2008 11:12:24 |
||
| 999 |
_c13974 _d13974 |
||